Status:
NOT_YET_RECRUITING
CES and EGChatbot in Reducing Anxiety, Depression, Insomnia, and Mental Risk
Lead Sponsor:
China Medical University Hospital
Conditions:
Depression, Anxiety
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The objective of this three-year study is to provide comprehensive care to young adults presenting with ARMS. The aim is use an exercise group (EGChat) developed by prior study and CES to decrease cog...
Detailed Description
In our previous study, the two-year psychosis transition rate was 8.33%, comparatively lower than rates reported in other international studies. Our findings highlight that individuals in the at-risk ...
Eligibility Criteria
Inclusion
- between 18 and 65 years old
- meet the DSM-5 criteria for ARMS as assessed by psychiatrists, who serve as the Co-PI of this research
- exhibit persistent symptoms without clinically significant fluctuations
- consent to participate in the study and provide written informed consent.
Exclusion
- have a DSM-5 diagnosis of intellectual disability or substance (including alcohol) use disorder
- possess a history of epilepsy, head trauma, central nervous system diseases, or frequent syncope
- are pregnant or lactating
- have an implanted neurostimulator or cardiac pacemaker
- have metal implants in the body
- non-removable cochlear implant
- are unable to adhere to the protocol (including the absence of a computer, tablet, or smartphone for use)
Key Trial Info
Start Date :
September 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2027
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06493695
Start Date
September 30 2024
End Date
April 30 2027
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University
Taichung, Taiwan, 40447